Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient

Recruiting now · Not applicable

Conditions studied: Aging

In brief

Evalution of the safety and tolerability of the oral administration of Salvia haenkei in a healthy population.

Key facts

Study ID: NCT05936346
Run by: IBSA Farmaceutici Italia Srl
People needed: 50
Starts: 2023-07-17
Expected to finish: 2025-04-30
Last updated by the study team: 2025-01-23

Who can join

Age: 55 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Informed consent as documented by signature
Male or female
Age 55-65 years, inclusive
In good general health as evidenced by medical history and current health status
Willingness to maintain dietary and sports habits as of baseline
Willingness and ability to comply with the requirements of the study

You may not qualify if…

Body Mass Index < 18.5 or ≥ 30
Difficulty in swallowing (dysphagia)
Known allergy or sensitivity to any ingredient of the study intervention
Any medical condition or clinically significant abnormalities in laboratory values (hematology, blood chemistry, urinalysis) at screening which in the judgment of the Investigator makes the subject unsuitable for the study
Planned or anticipated major surgical procedure during the subject's participation in this study
Inability or contraindications to undergo the study intervention
Inability to follow the procedures of the study (e.g. due to language problems, psychological disorders, dementia, etc.)
Use of any new vitamins, herbal or dietary supplements, functional foods and sports drink, of any kind, liable or presented as liable to enhance physical performances within one month prior to the start and during the study

Where it is running

Ospedale Regionale di Lugano — Lugano, Switzerland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.